Novacyt S.A.
OTC: NVYTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Lyn Dafydd Rees
- Employees
- 234
- Headquarters
- Le Vésinet, France
- IPO year
- 2021
- Market cap
- $34.8M
- Website
- https://www.novacyt.com
Loading NVYTF…
Loading profile data…Frequently asked questions about NVYTF
What does Novacyt S.A. (NVYTF) do?
Novacyt S.A., along with its subsidiaries, specializes in the global development, manufacturing, bespoke design, and commercialization of diagnostic products. These offerings are instrumental in identifying cancer and infectious diseases, reaching markets across the United Kingdom, Europe, the United States, Asia Pacific, the Middle East, and Af...
Where does NVYTF trade?
Novacyt S.A. (NVYTF) trades on the Other OTC.
What sector is NVYTF in?
Novacyt S.A. (NVYTF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Novacyt S.A.?
Lyn Dafydd Rees is the chief executive officer of Novacyt S.A. (NVYTF).
Where is Novacyt S.A. headquartered?
Novacyt S.A. is headquartered in France.
Does NVYTF pay a dividend?
Novacyt S.A. (NVYTF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NVYTF go public?
Novacyt S.A. (NVYTF) completed its initial public offering in 2021.